1. Home
  2. ANNX vs AHCO Comparison

ANNX vs AHCO Comparison

Compare ANNX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$3.49

Market Cap

726.1M

Sector

Health Care

ML Signal

N/A

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

N/A

Current Price

$7.40

Market Cap

752.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
AHCO
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
726.1M
752.4M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
ANNX
AHCO
Price
$3.49
$7.40
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
★ $17.00
$8.86
AVG Volume (30 Days)
★ 3.4M
2.5M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,244,857,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.91
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.36
$5.21
52 Week High
$7.18
$13.43

Technical Indicators

Market Signals
Indicator
ANNX
AHCO
Relative Strength Index (RSI) 36.30 62.30
Support Level N/A $5.48
Resistance Level $4.42 $10.92
Average True Range (ATR) 0.28 0.42
MACD -0.06 0.05
Stochastic Oscillator 10.82 74.41

Price Performance

Historical Comparison
ANNX
AHCO

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

Share on Social Networks: